Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: October 20, 2008
Last updated: February 2, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)